Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results

PURPOSE: To establish the maximum tolerated dose (MTD) of stereotactic body radiation therapy (SBRT) for locally advanced pancreatic head cancers. METHODS: A total of 16 patients were included in the single‐institution phase I dose‐escalation study. The initial dose level was 35 Gy in five fractions...

Descripción completa

Detalles Bibliográficos
Autores principales: Qing, Shuiwang, Gu, Lei, Zhang, Huojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495286/
https://www.ncbi.nlm.nih.gov/pubmed/34405577
http://dx.doi.org/10.1002/cam4.4214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495286/
https://www.ncbi.nlm.nih.gov/pubmed/34405577
http://dx.doi.org/10.1002/cam4.4214

Ejemplares similares